Fyles et al. NEJM 2004 | Hughes et al. CO 2013 | Pötter et al. Int J radiation Oncol Biol Phys 2007 | Blamey et al. Eur J Cancer 2013 | Kunkler Lancet Oncol 2015 | |
---|---|---|---|---|---|
Trial design | Multicenter, randomized | Multicenter, randomized | Multicenter, randomized | Multicenter, randomized | Multicenter, randomized |
Number of patients recruitment | 769 1992–2000 | 636 1994–1999 | 869 1996–2004 | 204 1992–2000 | 1326 2003–2009 |
Inclusion criteria: age | ≥50 years | ≥70 years | ≥50 yearsa | ≥50 years | ≥65 years |
Tumor diameter | <5 cm | <2 cm | <3 cm | <2 cm | <3 cm |
ER/PR positiv | 100% | 100% | 100% | 100% | 100% |
Her-2neu | unknown | unknown | unknown | unknown | Unknown, because this marker was not routinely assessed at the beginning of the trial |
Other main inclusion criteria | Postmenopausal status, MO | Postmenopausal status, MO | Postmenopausal status, MO | Postmenopausal status, MO | Postmenopausal status, MO |
Breast surgery | lumpectomy | lumpectomy | lumpectomy | Wide local excision | lumpectomy |